Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Lung |
Description | Lung Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for underserved, life-threatening lung |
Keywords | N/A |
WebSite | lungtx.com |
Host IP | 174.129.30.187 |
Location | United States |
Site | Rank |
US$15,140,397
Last updated: 2023-05-09 11:31:09
lungtx.com has Semrush global rank of 699,077. lungtx.com has an estimated worth of US$ 15,140,397, based on its estimated Ads revenue. lungtx.com receives approximately 1,746,969 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, lungtx.com is safe to visit. |
Purchase/Sale Value | US$15,140,397 |
Daily Ads Revenue | US$13,976 |
Monthly Ads Revenue | US$419,273 |
Yearly Ads Revenue | US$5,031,271 |
Daily Unique Visitors | 116,465 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
lungtx.com. | A | 1707 | IP: 174.129.30.187 |
lungtx.com. | NS | 300 | NS Record: dns4.name-services.com. |
lungtx.com. | NS | 300 | NS Record: dns3.name-services.com. |
lungtx.com. | NS | 300 | NS Record: dns1.name-services.com. |
lungtx.com. | NS | 300 | NS Record: dns2.name-services.com. |
lungtx.com. | NS | 300 | NS Record: dns5.name-services.com. |
lungtx.com. | MX | 1800 | MX Record: 10 aspmx.l.google.com. |
lungtx.com. | MX | 1800 | MX Record: 30 aspmx2.googlemail.com. |
lungtx.com. | MX | 1800 | MX Record: 20 alt2.aspmx.l.google.com. |
lungtx.com. | MX | 1800 | MX Record: 30 aspmx3.googlemail.com. |
lungtx.com. | MX | 1800 | MX Record: 20 alt1.aspmx.l.google.com. |
lungtx.com. | TXT | 1800 | TXT Record: MS=ms62282456 |
lungtx.com. | TXT | 1800 | TXT Record: Hlw-Oz-i2r= |
lungtx.com. | TXT | 1800 | TXT Record: v=spf1 include:_spf.google.com ~all |
Home About Overview Management Team Board of Directors Founders Medical Advisory Board Pipeline Overview LTI-01 LTI-03 News & Media Press Releases Posters & Publications Expanded Access Policy Contact Advancing First-in-Class Therapies for Underserved Lung Conditions At Lung Therapeutics, we have a highly promising product pipeline that features two leading programs: LTI-01 and LTI-03. Our goal is to provide better treatment options for patients with life-threatening lung conditions. Our Therapies Lung Therapeutics is developing first-in-class medicines for unmet medical needs in fibrosis and lung disease . LTI-01: A First-in-Class Treatment for LPE A pleural effusion is defined by the build-up of fluid in the pleural cavity, predominantly resulting from pneumonia. A loculated pleural effusion (LPE) occurs when scar tissue forms in the pleural cavity, trapping the fluid and preventing drainage. Our lead compound, LTI-01, is a proenzyme, or zymogen, designed to slowly activate in the |
HTTP/1.1 301 Moved Permanently Date: Sun, 31 Oct 2021 19:06:23 GMT Server: Apache Location: https://www.lungtx.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Sun, 31 Oct 2021 19:06:23 GMT Server: Apache X-Frame-Options: SAMEORIGIN Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Content-Type: text/html; charset=UTF-8 |
Domain Name: LUNGTX.COM Registry Domain ID: 1813699988_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2021-07-01T15:54:22Z Creation Date: 2013-07-08T15:50:58Z Registry Expiry Date: 2022-07-08T15:50:58Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.NAME-SERVICES.COM Name Server: DNS2.NAME-SERVICES.COM Name Server: DNS3.NAME-SERVICES.COM Name Server: DNS4.NAME-SERVICES.COM Name Server: DNS5.NAME-SERVICES.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T04:56:01Z <<< |